M&G Investment Management LTD Incyte Corp Transaction History

M&G Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$60.95 - $75.51 $4.91 Million - $6.09 Million	80,611 New	80,611 $5 Billion
Q4 2021 Jan 18, 2022	SELL	$63.34 - $74.11 $351,917 - $411,755	-5,556 Reduced 12.66%	38,317 $2.8 Million
Q1 2021 May 12, 2021	SELL	$76.02 - $100.5 $386,865 - $511,444	-5,089 Reduced 10.39%	43,873 $3.55 Million
Q3 2020 Oct 26, 2020	SELL	$85.07 - $109.69 $529,390 - $682,600	-6,223 Reduced 11.28%	48,962 $4.41 Million
Q2 2020 Jul 22, 2020	BUY	$74.18 - $108.93 $2.56 Million - $3.77 Million	34,567 Added 167.65%	55,185 $5.74 Million
Q4 2019 Jan 28, 2020	BUY	$73.04 - $95.72 $1.51 Million - $1.97 Million	20,618 New	20,618 $1.79 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.